Literature DB >> 2438080

Caeruloplasmin, prealbumin and alpha 2-macroglobulin as potential indices of disease activity in different arthritides.

K E Surrall, H A Bird, J S Dixon.   

Abstract

Caeruloplasmin (Cp), prealbumin and alpha 2-macroglobulin (alpha 2-M) concentrations in serum were compared in rheumatoid arthritis (RA), osteoarthrosis, ankylosing spondylitis, psoriatic arthritis, Reiter's syndrome, Behçet's syndrome, SLE and normal controls. Cp was significantly elevated (p less than 0.01) in all disease groups except for Reiter's syndrome and SLE. Prealbumin was only significantly depressed (p less than 0.01) in RA. The most notable elevation in alpha 2-macroglobulin occurred in Reiter's syndrome. However, these differences were generally still within the normal range, and hence these proteins are unlikely to offer alternative indices of disease activity suitable for monitoring the the progress of seronegative arthropathies.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2438080     DOI: 10.1007/bf02201003

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  13 in total

1.  Albumin metabolism in rheumatoid arthritis.

Authors:  F C Ballantyne; A Fleck; W C Dick
Journal:  Ann Rheum Dis       Date:  1971-05       Impact factor: 19.103

2.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

3.  Serum ceruloplasmin concentration in rheumatoid arthritis, ankylosing spondylitis, psoriasis and sarcoidosis.

Authors:  P Koskelo; M Kekki; M Virkkunen; A Lassus; T Somer
Journal:  Acta Rheumatol Scand       Date:  1966

4.  Reiter's syndrome. Evaluation of preliminary criteria for definite disease.

Authors:  R F Willkens; F C Arnett; T Bitter; A Calin; L Fisher; D K Ford; A E Good; A T Masi
Journal:  Arthritis Rheum       Date:  1981-06

5.  Raised serum copper and caeruloplasmin levels in subjects taking oral contraceptives.

Authors:  M E Carruthers; C B Hobbs; R L Warren
Journal:  J Clin Pathol       Date:  1966-09       Impact factor: 3.411

6.  Serum copper and caeruloplasmin are higher in seropositive than seronegative rheumatoid arthritis.

Authors:  P Oriente; R Scarpa; M Cutolo; A Riccio; A Pucino; L Postiglione
Journal:  Eur J Rheumatol Inflamm       Date:  1983

7.  Is there more than one signal for an acute phase response?

Authors:  M B Richter; R J Coughlan; G S Panayi; Y Gordon
Journal:  J Rheumatol       Date:  1985-12       Impact factor: 4.666

Review 8.  Behçet disease (Behçet syndrome).

Authors:  T Shimizu; G E Ehrlich; G Inaba; K Hayashi
Journal:  Semin Arthritis Rheum       Date:  1979-05       Impact factor: 5.532

9.  Serum biochemistry in rheumatoid arthritis, seronegative arthropathies, osteoarthritis, SLE and normal subjects.

Authors:  N G Sitton; J S Dixon; H A Bird; V Wright
Journal:  Br J Rheumatol       Date:  1987-04

10.  C-reactive protein in the serial assessment of disease activity in rheumatoid arthritis.

Authors:  J S Dixon; H A Bird; N G Sitton; M E Pickup; V Wright
Journal:  Scand J Rheumatol       Date:  1984       Impact factor: 3.641

View more
  4 in total

Review 1.  Biomarker development for axial spondyloarthritis.

Authors:  Matthew A Brown; Zhixiu Li; Kim-Anh Lê Cao
Journal:  Nat Rev Rheumatol       Date:  2020-06-30       Impact factor: 20.543

2.  Caeruloplasmin concentration and oxidase activity in polyarthritis.

Authors:  J S Dixon; M Greenwood; J R Lowe
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

3.  Calprotectin (S100A8/9) as serum biomarker for clinical response in proof-of-concept trials in axial and peripheral spondyloarthritis.

Authors:  Maureen C Turina; Nataliya Yeremenko; Jacqueline E Paramarta; Leen De Rycke; Dominique Baeten
Journal:  Arthritis Res Ther       Date:  2014-08-19       Impact factor: 5.156

4.  Serum inflammatory biomarkers fail to identify early axial spondyloarthritis: results from the SpondyloArthritis Caught Early (SPACE) cohort.

Authors:  Maureen C Turina; Nataliya Yeremenko; Floris van Gaalen; Maikel van Oosterhout; Inger J Berg; Ramona Ramonda; Cristina M C Lebre; Robert Landewé; Dominique Baeten
Journal:  RMD Open       Date:  2017-01-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.